Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Better Therapeutics, Inc. - Common Stock (NQ:BTTX)

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Mar 15, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Better Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
News headline image
Better Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Updates
From Better Therapeutics, Inc.
Via Business Wire
News headline image
Better Therapeutics to Release Third Quarter 2022 Financial Results and Provide Business Update on November 14, 2022
From Better Therapeutics, Inc.
Via Business Wire
News headline image
Better Therapeutics Appoints Diane Gomez-Thinnes as Chief Commercial Officer
From Better Therapeutics, Inc.
Via Business Wire
News headline image
Better Therapeutics Seeks FDA Approval For First Digital Therapeutic For Type 2 Diabetes ↗
 
Via Benzinga
News headline image
Why Better Therapeutics Shares Are Surging During Premarket Session ↗
 
Via Benzinga
News headline image
Insider Buying 2022: 15 Stocks to Bet On Despite the Bear Market ↗
Following insider buying is a savvy way for retail investors to profit even when a bear market is raging on Wall Street. Here are 15 stocks. 
Via InvestorPlace
News headline image
Positive Results from Pivotal Trial of Better Therapeutics’ Investigational BT-001 Prescription Digital Therapy for Type 2 Diabetes Published in Diabetes Care
From Better Therapeutics, Inc.
Via Business Wire
News headline image
Better Therapeutics Submits De Novo Request to U.S. FDA for BT-001 Investigational Prescription Digital Therapy for Type 2 Diabetes
From Better Therapeutics, Inc.
Via Business Wire
News headline image
Hoth Therapeutics And 3 Other Stocks Under $3 Insiders Are Aggressively Buying ↗
The Dow Jones jumped by around 197 points on Monday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around... 
Via Benzinga
News headline image
Bridgeline Digital And 2 Other Penny Stocks Insiders Are Aggressively Buying ↗
The Nasdaq 100 dropped by more than 200 points on Thursday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern... 
Via Benzinga
News headline image
Better Therapeutics to Participate in Three Upcoming Investor Conferences
From Better Therapeutics
Via Business Wire
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗
Good morning, investor! Let's get right into the biggest pre-market stock movers on Monday that traders will want to watch! 
Via InvestorPlace
News headline image
Why Amazon Shares Traded Lower; Here Are 74 Biggest Movers From Yesterday ↗
Gainers Bright Minds Biosciences Inc. (NASDAQ: DRUG) shares jumped 72.8% to close at $2.16 on Monday as the stock continued to see momentum despite the company last week announcing it is not aware of... 
Via Benzinga
News headline image
Why AMC Entertainment Is Trading Lower By 33%; Here Are 31 Stocks Moving Premarket ↗
Gainers Kiromic BioPharma, Inc. (NASDAQ: KRBP) shares rose 48.5% to $0.56 in pre-market trading. Kiromic Biopharma said the company has determined not to pursue, at this time, the contemplated public... 
Via Benzinga
News headline image
Better Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Update
From Better Therapeutics, Inc.
Via Business Wire
News headline image
Better Therapeutics to Release Second Quarter 2022 Financial Results and Provide Business Update on August 11, 2022
From Better Therapeutics, Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
  
Via Benzinga
News headline image
Why Shares Of Cannabis Companies Traded Higher; Here Are 101 Biggest Movers From Yesterday ↗
Gainers MMTec, Inc. (NASDAQ: MTC) shares gained 390.6% to close at $7.85 on Tuesday amid volatility in nano-cap Chinese stocks. 
Via Benzinga
News headline image
Why Applied DNA Sciences Is Trading Higher By 166%, Here Are 75 Stocks Moving In Tuesday's Mid-Day Session ↗
Gainers AMTD IDEA Group (NYSE: AMTD) shares jumped 284% to $8.00 after jumping 18% on Monday. The company owns 90%+ of AMTD Digital. 
Via Benzinga
News headline image
Recap Of Thursday's Biotech Catalysts - End of The Day Summary ↗
 
Via Benzinga
News headline image
Why Revlon Shares Jumped 90%; Here Are 83 Biggest Movers From Yesterday ↗
Gainers Liberty TripAdvisor Holdings, Inc. (NASDAQ: LTRPB) shares jumped 187.3% to close at $48.03 on Monday after gaining around 18% on Friday. 
Via Benzinga
News headline image
This Healthcare Stock Tumbled 43%; Here Are 88 Biggest Movers From Yesterday ↗
Gainers Athersys, Inc. (NASDAQ: ATHX) climbed 71.1% to close at $0.3250 on Thursday after gaining 10% on Wednesday. Athersys is expected to release its Q2 financial results on Thursday, August 11,... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
  
Via Benzinga
News headline image
Why Shares of Solar Companies Are Trading Higher? 64 Stocks Moving In Thursday's Mid-Day Session ↗
Gainers 
Via Benzinga
News headline image
Why Are Hydrogen Stocks PLUG, FCEL, BE Heating Up Today? ↗
Hydrogen stocks are climbing higher on Thursday thanks to news of Democrats reaching an agreement on climate change legislation. 
Via InvestorPlace
News headline image
Why Is Better Therapeutics (BTTX) Stock Up 27% Today? ↗
Better Therapeutics (BTTX) stock is rocketing higher on Thursday as investors react to results from a Phase 2 clinical trial. 
Via InvestorPlace
News headline image
Better Therapeutics' Shares Shoot Higher Following Positive Results From Type 2 Diabetes Study ↗
Better Therapeutics (NASDAQ: BTTX) announced positive results from its pivotal clinical trial for BT-001, prescription digital therapeutic that is designed to use nCBT to treat c diabetes (T2D). 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
  
Via Benzinga
News headline image
Better Therapeutics Completes Pivotal Trial of BT-001 for Type 2 Diabetes and Announces Positive Secondary Endpoint Results Following the Earlier Announcement of Positive Primary Endpoint Results
From Better Therapeutics, Inc.
Via Business Wire
News headline image
Better Therapeutics to Host Conference Call to Review Results from Pivotal Clinical Trial of BT-001 for Type 2 Diabetes
From Better Therapeutics, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.